Rohm & Haas, the specialty-chemicals maker embroiled in an acquisition fight with Dow Chemical, said today that its fourth-quarter earnings fell 82 percent as several charges and a drop in sales sapped profits.
Rohm & Haas, the specialty-chemicals maker embroiled in an acquisition fight with Dow Chemical, said today that its fourth-quarter earnings fell 82 percent as several charges and a drop in sales sapped profits.